ATLANTIC CITY, N.J. - (Mealey's) The first trial in New Jersey's Levaquin mass tort litigation ended Oct. 14 with a defense verdict for Johnson & Johnson and subsidiary Ortho-McNeil-Janssen Pharmaceuticals Inc. ( Paul Gaffney v. Johnson &... Read More
MINNEAPOLIS -- The second trial in the Levaquin antibiotic multidistrict litigation ended in a defense verdict June 17 when a jury in the U.S. District Court for the District of Minnesota found that defendant Ortho-McNeil-Janssen Pharmaceuticals Inc.... Read More
ST. LOUIS — (Mealey’s) The Eighth Circuit U.S. Court of Appeals on Nov. 30 unanimously affirmed denial of judgment as a matter of law or new trial for compensatory damages in the first Levaquin multidistrict litigation bellwether trial but... Read More
MINNEAPOLIS - (Mealey's) A Minnesota federal jury on Dec. 8 awarded a plaintiff in the first Levaquin multidistrict litigation bellwether trial a total of $1,815,000 in compensatory and punitive damages after finding that manufacturer Ortho-McNeil... Read More
WASHINGTON, D.C. - (AP) The Supreme Court is staying out of a dispute between Nigerian families and Pfizer, Inc., over the drug maker's use of a new antibiotic on children during a deadly outbreak of meningitis in the mid-1990s. The justices on Tuesday... Read More
NEW YORK - (AP) A "growing and dangerous" trend of antibiotic resistance among humans that has been traced in part to the overuse of antibiotics in animal feed led several health and consumer organizations to sue the U.S. government Wednesday... Read More
PROVIDENCE, R.I. - (AP) The American subsidiary of a major British drug maker, GlaxoSmithKline LLC, has agreed to pay more than $40 million to 37 states and Washington, D.C., to settle complaints alleging manufacturing process issues at a now-shuttered... Read More